SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 47.13 |
| Enterprise Value ($M) | 9.70 |
| Book Value ($M) | 37.02 |
| Book Value / Share | 2.55 |
| Price / Book | 1.27 |
| NCAV ($M) | 36.75 |
| NCAV / Share | 2.53 |
| Price / NCAV | 1.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.14 |
| Return on Assets (ROA) | -0.13 |
| Return on Equity (ROE) | -0.13 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 59.01 |
| Current Ratio | 59.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.59 |
| Assets | 37.86 |
| Liabilities | 0.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -7.14 |
| Net Income | -5.34 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -5.01 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Allostery Investments LP | 7.30 | ||
| 13G | Janus Henderson Group Plc | 7.40 | ||
| 13G | Avidity Partners Management LP | 6.90 | ||
| 13G/A | Western Standard LLC | 9.80 | 49.34 | |
| 13D | Adage Capital Management, L.P. | 8.28 | ||
| 13G/A | BML Investment Partners, L.P. | 4.90 | -17.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 59,703 | 921,930 | 6.48 | |
| 44,436 | 216,675 | 20.51 | |
| 23,459 | 93,209 | 25.17 | |
| 61,075 | 74,105 | 82.42 | |
| 18,841 | 31,002 | 60.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AADI – Aadi Bioscience, Inc. | ABEO – Abeona Therapeutics Inc. |
| ABVC – ABVC BioPharma, Inc. | ACB – Aurora Cannabis Inc. |
Financial data and stock pages provided by
Fintel.io